Trial Profile
Special Investigation of Kaletra in Pregnant Women.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Jan 2012
Price :
$35
*
At a glance
- Drugs Lopinavir/ritonavir (Primary)
- Indications HIV infections; Pregnancy
- Focus Adverse reactions
- Sponsors Abbott Laboratories
- 25 Jan 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 04 Mar 2010 New trial record